Table 4. Associations Between CHRN SNPs and Dependence Phenotypes in the Case–Control Sample.
SNP | GENE | POS (BP) | Min (AA/EA) | MAF AA | MAF EA |
Alcohol dependence |
Cocaine dependence |
Opioid dependence |
Nicotine dependence |
||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AA (N=1537) |
EA (N=1016) |
AA (N=1708) |
EA (N=1186) |
AA (N=1721) |
EA (N=1210) |
AA (N=1745) |
EA (N=1232) |
||||||||||||||||||||||
OR | P | Pemp | OR | P | Pemp | OR | P | Pemp | OR | P | Pemp | OR | P | Pemp | OR | P | Pemp | OR | P | Pemp | OR | P | Pemp | ||||||
rs3841324 | CHRNA5 | 76644868 | A | 0.21 | 0.37 | 0.78 | 0.03 | 0.28 | 0.87 | 0.34 | 0.94 | 0.87 | 0.25 | 0.99 | 0.96 | 0.88 | 1 | 0.93 | 0.43 | 1 | 1.03 | 0.41 | 1 | 0.95 | 0.70 | 1 | 1.02 | 0.55 | 1 |
rs684513 | CHRNA5 | 76645455 | G | 0.20 | 0.24 | 1.24 | 0.04 | 0.63 | 1.15 | 0.32 | 0.99 | 1.43 | 0.002 | 0.01 | 1.03 | 0.47 | 1 | 0.79 | 0.04 | 0.83 | 1.08 | 0.16 | 1 | 1.07 | 0.65 | 1 | 1.00 | 0.72 | 1 |
rs621849 | CHRNA5 | 76659916 | G | 0.43 | 0.39 | 0.80 | 0.007 | 0.14 | 0.92 | 0.46 | 0.99 | 0.82 | 0.02 | 0.30 | 1.00 | 0.86 | 1 | 1.10 | 0.25 | 1 | 1.07 | 0.39 | 0.99 | 0.88 | 0.08 | 0.83 | 1.03 | 0.59 | 1 |
rs16969968 | CHRNA5 | 76669980 | A | 0.06 | 0.34 | 0.99 | 0.763 | 1 | 0.98 | 0.74 | 1 | 1.14 | 0.54 | 1 | 0.98 | 0.61 | 1 | 1.45 | 0.23 | 0.64 | 0.90 | 0.08 | 0.98 | 1.43 | 0.02 | 0.30 | 1.06 | 0.93 | 1 |
rs615470 | CHRNA5 | 76673043 | T | 0.39 | 0.35 | 0.77 | 0.0004 | 0.02 | 0.85 | 0.22 | 0.93 | 0.84 | 0.04 | 0.51 | 0.90 | 0.37 | 0.99 | 1.00 | 0.69 | 1 | 0.99 | 0.98 | 1 | 0.89 | 0.11 | 0.96 | 0.95 | 0.96 | 1 |
rs578776 | CHRNA3 | 76675455 | G/A | 0.45 | 0.31 | 0.78 | 0.002 | 0.03 | 1.17 | 0.13 | 0.96 | 0.89 | 0.20 | 0.99 | 1.09 | 0.28 | 0.99 | 1.13 | 0.24 | 0.99 | 1.17 | 0.02 | 0.81 | 0.98 | 0.80 | 1 | 0.98 | 0.78 | 1 |
rs6495307 | CHRNA3 | 76677376 | T | 0.41 | 0.39 | 0.82 | 0.01 | 0.30 | 0.82 | 0.11 | 0.65 | 0.87 | 0.19 | 0.93 | 0.87 | 0.23 | 0.94 | 1.01 | 0.69 | 1 | 0.97 | 0.94 | 1 | 0.94 | 0.53 | 1 | 0.93 | 0.80 | 1 |
rs1051730 | CHRNA3 | 76681394 | A | 0.11 | 0.35 | 1.05 | 0.49 | 1 | 1.02 | 0.82 | 1 | 0.98 | 0.66 | 1 | 0.97 | 0.41 | 1 | 1.17 | 0.64 | 1 | 0.86 | 0.02 | 0.65 | 1.15 | 0.20 | 1 | 1.07 | 0.78 | 1 |
rs3743078 | CHRNA3 | 76681814 | G/C | 0.41 | 0.27 | 0.79 | 0.006 | 0.07 | 1.13 | 0.11 | 0.99 | 0.86 | 0.07 | 0.88 | 1.02 | 0.64 | 1 | 1.25 | 0.04 | 0.30 | 1.12 | 0.11 | 0.99 | 0.96 | 0.70 | 1 | 0.92 | 0.65 | 1 |
rs12914385 | CHRNA3 | 76685778 | T | 0.18 | 0.38 | 0.98 | 0.9631 | 1 | 1.02 | 0.83 | 1 | 0.99 | 0.84 | 1 | 0.98 | 0.58 | 1 | 1.00 | 0.56 | 1 | 0.91 | 0.13 | 0.99 | 1.22 | 0.05 | 0.51 | 1.13 | 0.37 | 0.93 |
rs2869546 | CHRNA3 | 76694400 | C | 0.38 | 0.36 | 0.82 | 0.009 | 0.30 | 0.80 | 0.09 | 0.58 | 0.96 | 0.60 | 1 | 0.91 | 0.45 | 0.99 | 0.89 | 0.31 | 1 | 0.98 | 0.89 | 1 | 0.94 | 0.35 | 1 | 0.95 | 0.78 | 1 |
rs8040868 | CHRNA3 | 76698236 | C | 0.34 | 0.41 | 1.07 | 0.33 | 1 | 1.09 | 0.76 | 0.99 | 0.94 | 0.56 | 1 | 1.01 | 0.67 | 1 | 1.06 | 0.97 | 1 | 0.91 | 0.09 | 0.99 | 1.00 | 0.94 | 1 | 1.09 | 0.54 | 0.99 |
rs11637890 | CHRNB4 | 76722474 | G | 0.15 | 0.35 | 0.85 | 0.24 | 0.99 | 0.92 | 0.25 | 1 | 0.91 | 0.93 | 1 | 0.96 | 0.61 | 1 | 1.20 | 0.10 | 0.99 | 1.06 | 0.41 | 1 | 0.91 | 0.91 | 1 | 1.03 | 0.66 | 1 |
Abbreviations: AA, African American; EA, European American; MAF, minor allele frequency; Min, minor allele; P, Raw P-value; Pemp, Empirical P-value based on 1000 null simulations; OR, odds ratio for each additional copy of the minor allele.
Values with an experiment-wide significance less than 0.05 are in bold.
N indicates the total number of subjects contributing to each analysis.